May patients receiving 5-alpha-reductase inhibitors be in higher risk of COVID-19 complications?
Sign Up to like & getrecommendations! Published in 2020 at "Medical Hypotheses"
DOI: 10.1016/j.mehy.2020.109751
Abstract: Abstract COVID-19 pandemic is a major challenge for global and national healthcare providers. Number of new cases is continuously increasing with an emerging trend showing worse prognosis in males in comparison to females. Based on… read more here.
Keywords: may patients; alpha reductase; patients receiving; receiving alpha ... See more keywords